These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32157448)

  • 1. Correction to: Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.
    Wu Q; Liu J; Zhang Y; Wu S; Xie X
    Cancer Immunol Immunother; 2020 Jun; 69(6):937. PubMed ID: 32157448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.
    Wu Q; Liu J; Zhang Y; Wu S; Xie X
    Cancer Immunol Immunother; 2020 Jun; 69(6):927-936. PubMed ID: 32076793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction to: Expression of the immune checkpoint VISTA in breast cancer.
    Zong L; Mo S; Yu S; Zhou Y; Zhang M; Chen J; Xiang Y
    Cancer Immunol Immunother; 2020 Aug; 69(8):1447. PubMed ID: 32556445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in predictive biomarkers associated with immune checkpoint inhibitors for tumor therapy].
    Guo R; Li X; Hao M; Liang Y; Wang L; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1403-1424. PubMed ID: 37154314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.
    Kudura K; Ritz N; Kutzker T; Hoffmann MHK; Templeton AJ; Foerster R; Kreissl MC; Antwi K
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction to: Strategies for Predicting Response to Checkpoint Inhibitors.
    Zappasodi R; Wolchok JD; Merghoub T
    Curr Hematol Malig Rep; 2019 Feb; 14(1):62. PubMed ID: 30406880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy.
    Gao Y; Wu C; Chen X; Ma L; Zhang X; Chen J; Liao X; Liu M
    Front Immunol; 2022; 13():1049043. PubMed ID: 36341331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress.
    Perrino M; De Vincenzo F; Cordua N; Borea F; Aliprandi M; Santoro A; Zucali PA
    Front Immunol; 2023; 14():1121557. PubMed ID: 36776840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis.
    Deng HY; Chen ZJ; Qiu XM; Zhu DX; Tang XJ; Zhou Q
    Nutrition; 2021 Oct; 90():111345. PubMed ID: 34166897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors.
    Zou XL; Chen WY; Zhang GY; Ke H; Yang QH; Li XB
    Front Pharmacol; 2021; 12():747075. PubMed ID: 34819857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography molecular imaging to monitor anti-tumor systemic response for immune checkpoint inhibitor therapy.
    Xing X; Zhao Q; Zhou J; Zhou R; Liu Y; Qin X; Zhang M; Zhong Y; Wang J; Tian M; Zhang H
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1671-1688. PubMed ID: 36622406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of
    Ling T; Zhang L; Peng R; Yue C; Huang L
    Front Immunol; 2022; 13():1014063. PubMed ID: 36466905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.
    Kiamanesh Z; Ayati N; Sadeghi R; Hawkes E; Lee ST; Scott AM
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4661-4676. PubMed ID: 35932329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
    Hu X; Xu H; Xue Q; Wen R; Jiao W; Tian K
    Mol Med; 2021 Oct; 27(1):126. PubMed ID: 34620079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of 2-[
    Manson G; Lemchukwu AC; Mokrane FZ; Lopci E; Aide N; Vercellino L; Houot R; Dercle L
    Eur Radiol; 2022 Sep; 32(9):6536-6544. PubMed ID: 35344061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition.
    Kudura K; Ritz N; Templeton AJ; Kutzker T; Foerster R; Antwi K; Kreissl MC; Hoffmann MHK
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade.
    Natoli M; Bonito N; Robinson JD; Ghaem-Maghami S; Mao Y
    Cancer Immunol Immunother; 2020 Aug; 69(8):1403-1408. PubMed ID: 32556444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction to: Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis.
    Arbel R; Aboalhasan E; Hammerman A; Azuri J
    Clin Drug Investig; 2020 Aug; 40(8):773. PubMed ID: 32506236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging biomarkers for immune checkpoint inhibitor therapy.
    van de Donk PP; Kist de Ruijter L; Lub-de Hooge MN; Brouwers AH; van der Wekken AJ; Oosting SF; Fehrmann RS; de Groot DJA; de Vries EG
    Theranostics; 2020; 10(4):1708-1718. PubMed ID: 32042331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction to: Knock-on effect of periodontitis to the pathogenesis of Alzheimer's disease?
    Leblhuber F; Huemer J; Steiner K; Gostner JM; Fuchs D
    Wien Klin Wochenschr; 2020 Sep; 132(17-18):549-550. PubMed ID: 32253627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.